Ewing S Sarcoma clinical trials

Explore recruiting ewing s sarcoma clinical trials.

Also recruiting in Europe

Ewing S Sarcoma trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

REGOBONE_A Randomized Phase II, placebo-controlled, multicenter study evaluating efficacy and safety of regorafenib in patients with metastatic bone sarcomas

France

Therapeutic exploratory (Phase II) EU CTIS Study details

To evaluate the efficacy and safety of regorafenib in patients with refractory primary bone tumors.

Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

rEECur: International Randomised Controlled Trial of Chemotherapy for the Treatment of Recurrent and Primary Refractory Ewing Sarcoma

Czechia, Netherlands, Italy, Spain, Denmark, Finland +4 more

Phase II and Phase III (Integrated) EU CTIS Study details

Ewing S Sarcoma trials by city

Ewing S Sarcoma in Toronto Ewing S Sarcoma in Vancouver Ewing S Sarcoma in Montreal Ewing S Sarcoma in Calgary Ewing S Sarcoma in Edmonton Ewing S Sarcoma in Ottawa Ewing S Sarcoma in Winnipeg Ewing S Sarcoma in Quebec City Ewing S Sarcoma in Hamilton Ewing S Sarcoma in Kitchener Ewing S Sarcoma in London Ewing S Sarcoma in Halifax Ewing S Sarcoma in New York Ewing S Sarcoma in Los Angeles Ewing S Sarcoma in Chicago Ewing S Sarcoma in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease